GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Gallbladder and Pancreas/Native Hawaiian pancreatic cancer disparity study
66

Native Hawaiian pancreatic cancer disparity study

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated July 1, 2025

The study on pancreatic cancer disparities among Native Hawaiians, conducted as part of the Multiethnic Cohort Study, revealed significant findings about the heightened risk faced by this population compared to White individuals. Below is a detailed summary of the study and its findings:

Key Findings:

  1. Elevated Risk of Pancreatic Cancer:
  • Native Hawaiians were found to have a 71% higher risk of pancreatic cancer compared to White individuals, even after adjusting for established risk factors such as diabetes, obesity, smoking, alcohol use, and family history of cancer.
  • The incidence rates of pancreatic cancer were nearly double in Native Hawaiians (80.2 per 100,000 person-years) compared to Whites (44.6 per 100,000 person-years).
  1. Gender-Specific Risk:
  • The elevated risk persisted across both sexes:
  • Men: Hazard Ratio (HR) of 1.54.
  • Women: Hazard Ratio (HR) of 1.85.
  • This indicates that Native Hawaiian women face an even higher relative risk compared to White women.
  1. Impact of Comorbidities:
  • Risk of pancreatic cancer increased with the number of comorbidities (e.g., diabetes, obesity, smoking, alcohol use, or family history of cancer).
  • Native Hawaiian men with two or more risk factors had a fivefold greater risk compared to White men without any risk factors (HR 5.17).
  1. Diabetes as a Key Risk Factor:
  • Among Native Hawaiian men, diabetes was particularly impactful, tripling the risk of pancreatic cancer.
  1. Genetic and Environmental Contributions:
  • Genetic analyses suggested that the elevated risk in Native Hawaiians was independent of polygenic risk scores, indicating that other biological or environmental factors may be contributing to the disparity.

Implications:

The study concluded that the disproportionate burden of pancreatic cancer in Native Hawaiians likely stems from the higher prevalence and cumulative effect of risk factors in this population, particularly among men. This highlights the need for targeted interventions to address these disparities.

Recommendations:

  1. Targeted Prevention Strategies:
  • Developing culturally tailored prevention strategies to address modifiable risk factors such as diabetes, obesity, smoking, and alcohol use.
  1. Risk-Factor Modification:
  • Aggressive efforts to manage and reduce risk factors in high-risk Native Hawaiian populations.
  1. Exploration of Screening:
  • Researchers emphasized the potential benefits of exploring pancreatic cancer screening for high-risk Native Hawaiian individuals, given their elevated risk.
  1. Further Research:
  • Additional genetic and longitudinal studies are needed to better understand the mechanisms driving these disparities and to identify other potential contributors, whether biological, environmental, or social.

Conclusion:

The findings underscore the urgent need to address the unique health challenges faced by Native Hawaiians, particularly in the context of pancreatic cancer. By focusing on prevention, early detection, and further research, health disparities in this population can be better understood and mitigated.

Related Q&A

01

Olomorasib Receives FDA Breakthrough Therapy Designation in KRAS G12C–Mutant Pancreatic Cancer: FDA / Oncology Update | August 2026

Introduction: KRAS mutations drive the vast majority of pancreatic cancers, but KRAS G12C represents only about 1–2% of cases. This small molecular subgroup is increasingly actionable. The FDA...

02

A Simple Blood-Based Biomarker (SIRI) Predicts Outcomes in Metastatic Pancreatic Cancer: Pancreatology | August 2026

Introduction: Systemic inflammation plays a major role in pancreatic ductal adenocarcinoma (PDAC), contributing to tumor progression, cachexia, and treatment resistance. The Systemic Inflammation Response Index (SIRI) combines neutrophil,...

03

Higher Dietary Vitamin B6 Intake Is Associated With Lower Gallstone Prevalence: Medicine | August 2026

Introduction: Vitamin B6 participates in cholesterol metabolism, oxidative stress regulation, and inflammatory pathways that may influence gallstone formation. This population-based analysis examined whether dietary vitamin B6 intake is...

04

Fatty Pancreas Predicts Diabetes, Kidney Disease, and Cardiovascular Risk: UEG Journal | July 2026

Introduction: Fatty pancreas is increasingly recognized as an ectopic fat depot with metabolic consequences, but its clinical significance has been difficult to define because previous studies used inconsistent...

05

Nivolumab–Ipilimumab Shows Promising Activity in Gallbladder Cancer: Clinical Cancer Research | August 2026

Introduction: Dual immune checkpoint blockade with nivolumab plus ipilimumab has shown activity across several malignancies, but its role in advanced biliary tract cancer remains uncertain. The Phase II...

06

Targeting Cholesterol Metabolism is A New Strategy to Overcome Chemotherapy Resistance in Pancreatic Cancer: National Cancer Institute Research | August 2026

Introduction: Pancreatic ductal adenocarcinoma (PDAC) frequently develops resistance to chemotherapy through metabolic adaptations that enhance tumor survival. New research from the University of Oklahoma is investigating whether pancreatic...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer